GNP Guia Naghi & Partners The Legal 500 – The Clients Guide to Law Firms
-1
archive,tag,tag-ip,tag-438,theme-stockholm,qode-social-login-1.1.3,qode-restaurant-1.1.1,stockholm-core-1.1,woocommerce-no-js,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,side_area_over_content,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
25 March 2024 In Competition, europeanlaw, Fresh Perspectives, GNP, IP, PatentLitigation, Pharma, PharmaReport, VexatiousLitigation

Alexandra Stoicescu – Tales from the EC’s Latest Pharma Report: Where Patent Rights End and Abuse of Dominance Begins

On 26 January 2024, the European Commission (the „EC”) published a comprehensive report (the „Report”) aimed to outline the recent competition enforcement in the pharmaceutical sector carried out by the EC and the national competition authorities (the „NCAs”) from 2018 to 2022. This Report highlights

0
0